Evidence map›Paper›PMID 31981554›Full record

ArticleThe Lancet. Global health2020

The effect of acute malnutrition on enteric pathogens, moderate-to-severe diarrhoea, and associated mortality in the Global Enteric Multicenter Study cohort: a post-hoc analysis.

Kirkby D Tickell, Rumana Sharmin, Emily L Deichsel, Laura M Lamberti, Judd L Walson, A S G Faruque, Patricia B Pavlinac, Karen L Kotloff, Mohammod J Chisti

Registry-linked trialOpen access · goldAbstract readMulticenter Study
In one paragraph

Article in The Lancet. Global health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05519254 (Lactoferrin and Lysozyme Supplementation for Long-term Diarrhea Sequelae), which is not on this map. Cited by 50 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 3 pooled it
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05519254 phase3recruitingnot on this mapstarted 2023, after this paper: background citation

Lactoferrin and Lysozyme Supplementation for Long-term Diarrhea Sequelae

TypeinterventionalSponsorUniversity of WashingtonRan2023 to 2026Enrolled600ConditionsDiarrhea, Wasting, Malnutrition, ChildArmsLactoferrin, Lysozyme, Lactoferrin + Lysozyme, Placebo
3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 3 syntheses or guidelines pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Human vaccines & immunotherapeutics · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Lead-free perovskite KCsSnIScientific reports · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Kirkby D TickellDepartment of Global Health, University of Washington, Seattle, WA, USA; Department of Epidemiology, University of Washington, Seattle, WA, USA; Childhood Acute Illness and Nutrition (CHAIN) Network, Nairobi, Kenya. Electronic address: kirkbt@uw.edu.
Rumana SharminInternational Centre for Diarrheal Disease Research (icddr, b), Dhaka, Bangladesh.
Emily L DeichselCenter for Vaccine Development and Global Health, School of Medicine, University of Maryland, Baltimore, MD, USA.
Laura M LambertiThe Bill & Melinda Gates Foundation, Seattle, WA, USA.
Judd L WalsonDepartment of Global Health, University of Washington, Seattle, WA, USA; Department of Epidemiology, University of Washington, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA; Department of Pediatrics, University of Washington, Seattle, WA, USA; Childhood Acute Illness and Nutrition (CHAIN) Network, Nairobi, Kenya.
A S G FaruqueInternational Centre for Diarrheal Disease Research (icddr, b), Dhaka, Bangladesh.
Patricia B PavlinacDepartment of Global Health, University of Washington, Seattle, WA, USA.
Karen L KotloffCenter for Vaccine Development and Global Health, School of Medicine, University of Maryland, Baltimore, MD, USA.
Mohammod J ChistiChildhood Acute Illness and Nutrition (CHAIN) Network, Nairobi, Kenya; International Centre for Diarrheal Disease Research (icddr, b), Dhaka, Bangladesh.
International Centre for Diarrhoeal Disease Research · BDUniversity of Washington · USUniversity of Maryland, Baltimore · USBill & Melinda Gates Foundation · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHost vulnerabilities associated with acute malnutrition could facilitate the ability of specific enteric pathogens to cause diarrhoea and associated mortality. Using data from the Global Enteric Multicenter Study, we assessed whether acute malnutrition modifies the association between common enteric pathogens and moderate-to-severe diarrhoea, and whether associations between enteric pathogens and death were modified by acute malnutrition.

methodsChildren with moderate-to-severe diarrhoea and age-matched and community-matched controls were included in this post-hoc analysis if their mid-upper arm circumference had been measured and if they were older than 6 months of age. Acute malnutrition was defined as mid-upper arm circumference below 12·5 cm, capturing both severe acute malnutrition (<11·5 cm) and moderate acute malnutrition (≥11·5 cm and <12·5 cm). We tested whether acute malnutrition modified associations between enteric pathogens and moderate-to-severe diarrhoea in conditional logistic regression models. Among children with moderate-to-severe diarrhoea, Cox proportional hazards regression evaluated the modifying effect of acute malnutrition on the relationship between pathogens and 60-day fatality rate.

findingsThe age, site, and co-infection adjusted odds ratios (aORs) for moderate-to-severe diarrhoea associated with typical enteropathogenic Escherichia coli among children aged 6-11 months was 2·08 (95% CI 1·14-3·79) in children with acute malnutrition, and 0·97 (0·77-1·23) in children with better nutritional status, compared with healthy controls. Enterotoxigenic E coli producing heat-stable toxin among children aged 12-23 months also had a stronger association with moderate-to-severe diarrhoea in children with acute malnutrition (aOR 7·60 [2·63-21·95]) than among similarly aged children with better nutritional status (aOR 2·39 [1·76-3·25]). Results for Shigella spp, norovirus, and sapovirus suggested they had a stronger association with moderate-to-severe diarrhoea than other pathogens among children with better nutritional status, although Shigella spp remained associated with moderate-to-severe diarrhoea in both nutritional groups. 92 (64%) of 144 children with moderate-to-severe diarrhoea who died had acute malnutrition. Pathogen-specific 60-day fatality rates for all pathogens were higher among children with acute malnutrition, but no individual pathogen had a significantly larger increase in its relative association with mortality.

interpretationAcute malnutrition might strengthen associations between specific pathogens and moderate-to-severe diarrhoea. However, the strong link between acute malnutrition and mortality during moderate-to-severe diarrhoea in children is not limited to specific infections, and affects a broad spectrum of enteric pathogens. Interventions addressing acute malnutrition could be an effective way to lower the mortality of both childhood malnutrition and diarrhoea.

fundingThe Bill & Melinda Gates Foundation.

Indexed as

Cause of DeathMortalityBangladeshCase-Control StudiesChild, PreschoolCohort StudiesCoinfectionDiarrheaFemaleGambiaHumansIndiaInfantKenyaMaleMali

Identifiers

PMID31981554
PMCPMC7025322
OpenAlexW3001665102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.